American Assets Investment Management’s GSK GSK Stock Holding History

American Assets Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.21M	Hold	40,000	–	–	0.15%	116
2025 Q4	$1.96M	Hold	40,000	–	–	0.14%	118
2025 Q3	$1.73M	Hold	40,000	–	–	0.13%	118
2025 Q2	$1.54M	Hold	40,000	–	–	0.12%	123
2025 Q1	$1.55M	Hold	40,000	–	–	0.14%	125
2024 Q4	$1.35M	Hold	40,000	–	–	0.11%	129
2024 Q3	$1.64M	Hold	40,000	–	–	0.14%	129
2024 Q2	$1.54M	Hold	40,000	–	–	0.14%	128
2024 Q1	$1.71M	Hold	40,000	–	–	0.16%	123
2023 Q4	$1.48M	Hold	40,000	–	–	0.15%	127
2023 Q3	$1.45M	Hold	40,000	–	–	0.16%	126
2023 Q2	$1.43M	Hold	40,000	–	–	0.16%	128
2023 Q1	$1.42M	Hold	40,000	–	–	0.16%	125
2022 Q4	$1.41M	Hold	40,000	–	–	0.16%	120
2022 Q3	$1.18M	Hold	40,000	–	–	0.15%	123
2022 Q2	$2.18M	Hold	40,000	–	–	0.27%	96
2022 Q1	$2.18M	Hold	40,000	–	–	0.23%	101
2021 Q4	$2.21M	Hold	40,000	–	–	0.24%	102
2021 Q3	$1.91M	Hold	40,000	–	–	0.24%	102
2021 Q2	$1.99M	Hold	40,000	–	–	0.26%	96
2021 Q1	$1.78M	Hold	40,000	–	–	0.25%	96
2020 Q4	$1.84M	Hold	40,000	–	–	0.3%	89
2020 Q3	$1.88M	Hold	40,000	–	–	0.39%	78
2020 Q2	$2.04M	Buy	40,000 +12,000	+43%	+$616K	0.46%	62
2020 Q1	$1.33M	Hold	28,000	–	–	0.28%	92
2019 Q4	$1.65M	Hold	28,000	–	–	0.25%	103
2019 Q3	$1.49M	Hold	28,000	–	–	0.24%	107
2019 Q2	$1.4M	Hold	28,000	–	–	0.22%	111
2019 Q1	$1.47M	Hold	28,000	–	–	0.24%	110
2018 Q4	$1.34M	Hold	28,000	–	–	0.24%	103
2018 Q3	$1.42M	Hold	28,000	–	–	0.23%	116
2018 Q2	$1.39M	Hold	28,000	–	–	0.24%	108
2018 Q1	$1.37M	Buy	28,000 +4,000	+17%	+$186K	0.26%	106
2017 Q4	$1.06M	Hold	24,000	–	–	0.2%	115
2017 Q3	$1.22M	Hold	24,000	–	–	0.24%	112
2017 Q2	$1.29M	Hold	24,000	–	–	0.27%	100
2017 Q1	$1.26M	Hold	24,000	–	–	0.26%	101
2016 Q4	$1.16M	Buy	24,000 +8,000	+50%	+$395K	0.24%	103
2016 Q3	$863K	Hold	16,000	–	–	0.2%	104
2016 Q2	$867K	Buy	16,000 +8,000	+100%	+$421K	0.21%	99
2016 Q1	$406K	Hold	8,000	–	–	0.11%	112
2015 Q4	$404K	Hold	8,000	–	–	0.11%	116
2015 Q3	$385K	Hold	8,000	–	–	0.12%	109
2015 Q2	$417K	Buy	+8,000	New	+$450K	0.12%	104

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

American Assets Investment Management's GSK Position: Q1 2026 in Review

American Assets Investment Management held its GSK (GSK) position steady in Q1 2026 at 40,000 shares worth $2.21M. The position accounts for 0.15% of the portfolio, ranked #116.

American Assets Investment Management first reported a position in GSK in Q2 2015 and has held it in 44 quarters since. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

American Assets Investment Management held 40,000 shares of GSK worth $2.21M as of Q1 2026.
American Assets Investment Management left its GSK share count unchanged in Q1 2026.
GSK made up 0.15% of American Assets Investment Management's portfolio in Q1 2026, its #116 holding.
American Assets Investment Management first reported a position in GSK in Q2 2015 and has held it in 44 quarters since.
1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on American Assets Investment Management's 13F filing for Q1 2026, filed 11 May 2026.